• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

含3-酮去氧孕烯皮下植入剂的临床结果

Clinical results with subcutaneous implants containing 3-keto desogestrel.

作者信息

Olsson S E, Odlind V, Johansson E

机构信息

Department of Obstetrics and Gynecology, University of Uppsala, Sweden.

出版信息

Contraception. 1990 Jul;42(1):1-11. doi: 10.1016/0010-7824(90)90087-c.

DOI:10.1016/0010-7824(90)90087-c
PMID:2117514
Abstract

Eight healthy women using one Silastic implant of 30 mm length filled with 3-keto desogestrel, the active metabolite of desogestrel, were studied for 36-664 days. The release rate of 3-keto desogestrel was quite constant and around 30 micrograms/day. No ovulations occurred. One woman was amenorrheic, while the others had different bleeding patterns, often with periods of spotting. No other side effects were recorded. The mean plasma levels of 3-keto desogestrel were 0.9 nmol/l after 1 month and 0.5 nmol/l after 12 months. 3-Keto desogestrel was less effective than testosterone, estradiol or levonorgestrel in displacing 3H-dihydrotestosterone from SHBG. It is concluded that contraception with 3-keto desogestrel delivered through an implant is a promising method for further investigation. With a single implant we found a duration of at least one year.

摘要

八名健康女性使用了一根长度为30毫米、填充有地索高诺酮的活性代谢物3-酮地索高诺酮的硅橡胶植入物,研究时间为36至664天。3-酮地索高诺酮的释放速率相当恒定,约为30微克/天。未发生排卵现象。一名女性闭经,其他女性则有不同的出血模式,经常出现点滴出血。未记录到其他副作用。3-酮地索高诺酮的平均血浆水平在1个月后为0.9纳摩尔/升,12个月后为0.5纳摩尔/升。在从性激素结合球蛋白(SHBG)置换3H-二氢睾酮方面,3-酮地索高诺酮的效果不如睾酮、雌二醇或左炔诺孕酮。结论是,通过植入物递送3-酮地索高诺酮进行避孕是一种有前景的可供进一步研究的方法。使用单个植入物,我们发现其有效期至少为一年。

相似文献

1
Clinical results with subcutaneous implants containing 3-keto desogestrel.含3-酮去氧孕烯皮下植入剂的临床结果
Contraception. 1990 Jul;42(1):1-11. doi: 10.1016/0010-7824(90)90087-c.
2
Serum steroid binding protein concentrations, distribution of progestogens, and bioavailability of testosterone during treatment with contraceptives containing desogestrel or levonorgestrel.使用含去氧孕烯或左炔诺孕酮的避孕药治疗期间血清类固醇结合蛋白浓度、孕激素分布及睾酮的生物利用度。
Fertil Steril. 1984 Jul;42(1):44-51. doi: 10.1016/s0015-0282(16)47956-2.
3
Contraception with a vaginal ring releasing 3-keto desogestrel and ethinylestradiol.含3-酮去氧孕烯和炔雌醇的阴道环避孕法。
Contraception. 1990 Nov;42(5):563-72. doi: 10.1016/0010-7824(90)90083-8.
4
A cross-over study of three oral contraceptives containing ethinyloestradiol and either desogestrel or levonorgestrel.一项关于三种含乙炔雌二醇与去氧孕烯或左炔诺孕酮的口服避孕药的交叉研究。
Contraception. 1992 Jun;45(6):523-32. doi: 10.1016/0010-7824(92)90103-z.
5
The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.不同剂型口服避孕药对脂质和碳水化合物代谢的影响。
N Engl J Med. 1990 Nov 15;323(20):1375-81. doi: 10.1056/NEJM199011153232003.
6
Oral contraceptives containing 20 or 30 micrograms ethinylestradiol and 150 micrograms desogestrel: pharmacokinetics and pharmacodynamic parameters.含20或30微克乙炔雌二醇和150微克去氧孕烯的口服避孕药:药代动力学和药效学参数。
Horm Res. 1991;36(5-6):238-46. doi: 10.1159/000182172.
7
Serum pharmacokinetics of orally administered desogestrel and binding of contraceptive progestogens to sex hormone-binding globulin.口服去氧孕烯的血清药代动力学及避孕孕激素与性激素结合球蛋白的结合
Am J Obstet Gynecol. 1990 Dec;163(6 Pt 2):2132-7. doi: 10.1016/0002-9378(90)90553-j.
8
Release characteristics, ovarian activity and menstrual bleeding pattern with a single contraceptive implant releasing 3-ketodesogestrel.含单一释放 3-酮去氧孕烯的避孕植入剂的释放特性、卵巢活性及月经出血模式
Contraception. 1993 Mar;47(3):251-61. doi: 10.1016/0010-7824(93)90042-6.
9
Selectivity in progesterone and androgen receptor binding of progestagens used in oral contraceptives.口服避孕药中使用的孕激素在孕酮和雄激素受体结合方面的选择性。
Contraception. 1988 Sep;38(3):325-32. doi: 10.1016/0010-7824(88)90104-7.
10
Pharmacodynamics of a contraceptive vaginal ring releasing 3-keto-desogestrel.释放3-酮去氧孕烯的避孕阴道环的药效学
Contraception. 1989 Jun;39(6):653-64. doi: 10.1016/0010-7824(89)90040-1.

引用本文的文献

1
Contraceptive vaginal ring effectiveness is maintained during 6 weeks of use: a prospective study of normal BMI and obese women.避孕阴道环在使用 6 周内仍保持有效:对正常 BMI 和肥胖女性的前瞻性研究。
Contraception. 2013 Apr;87(4):432-6. doi: 10.1016/j.contraception.2012.12.001. Epub 2012 Dec 10.